ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
156 EUR
+3.2 (+2.09%)
ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 71 industry peers in the Chemicals industry. ACT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACT is quite expensive at the moment. It does show a decent growth rate. This makes ACT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year ACT was profitable.
- ACT had a positive operating cash flow in the past year.
- ACT had positive earnings in each of the past 5 years.
- ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of ACT (10.49%) is better than 94.37% of its industry peers.
- With an excellent Return On Equity value of 26.47%, ACT belongs to the best of the industry, outperforming 94.37% of the companies in the same industry.
- ACT's Return On Invested Capital of 13.45% is amongst the best of the industry. ACT outperforms 91.55% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ACT is above the industry average of 7.19%.
- The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
- ACT has a better Profit Margin (10.97%) than 81.69% of its industry peers.
- In the last couple of years the Profit Margin of ACT has grown nicely.
- Looking at the Operating Margin, with a value of 15.93%, ACT belongs to the top of the industry, outperforming 83.10% of the companies in the same industry.
- ACT's Operating Margin has improved in the last couple of years.
- The Gross Margin of ACT (66.55%) is better than 97.18% of its industry peers.
- In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
- ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, ACT has less shares outstanding
- Compared to 5 years ago, ACT has less shares outstanding
- Compared to 1 year ago, ACT has an improved debt to assets ratio.
2.2 Solvency
- ACT has an Altman-Z score of 5.01. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.01, ACT belongs to the best of the industry, outperforming 87.32% of the companies in the same industry.
- The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
- ACT has a Debt to FCF ratio of 1.32. This is amongst the best in the industry. ACT outperforms 94.37% of its industry peers.
- ACT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
- ACT has a better Debt to Equity ratio (0.16) than 73.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 5.01 |
ROIC/WACC1.85
WACC7.29%
2.3 Liquidity
- A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
- ACT's Current ratio of 2.87 is amongst the best of the industry. ACT outperforms 83.10% of its industry peers.
- ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ACT (1.77) is better than 81.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
- ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
- The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
- ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.05%.
- ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
- Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 20.26% on average per year.
- Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y21.07%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
EPS Next 5Y20.26%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- ACT is valuated quite expensively with a Price/Earnings ratio of 25.57.
- The rest of the industry has a similar Price/Earnings ratio as ACT.
- Compared to an average S&P500 Price/Earnings ratio of 28.87, ACT is valued at the same level.
- ACT is valuated rather expensively with a Price/Forward Earnings ratio of 24.11.
- ACT's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 25.96. ACT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.57 | ||
| Fwd PE | 24.11 |
4.2 Price Multiples
- 60.56% of the companies in the same industry are cheaper than ACT, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.39 | ||
| EV/EBITDA | 13.11 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ACT may justify a higher PE ratio.
- A more expensive valuation may be justified as ACT's earnings are expected to grow with 18.06% in the coming years.
PEG (NY)1.21
PEG (5Y)1.04
EPS Next 2Y12.7%
EPS Next 3Y18.06%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.16%, ACT has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 2.45, ACT is paying slightly less dividend.
- ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
- The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- ACT pays out 49.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
- ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.16%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status for ACT stock?
ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
Can you provide the financial health for ACT stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.
What is the earnings growth outlook for ALZCHEM GROUP AG?
The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 21.07% in the next year.